Bulletin
Investor Alert

Anthem Inc.

NYS: ANTM

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 4, 2020, 4:15 p.m.

/zigman2/quotes/203808743/composite

$

323.27

Change

0.00 0.00%

Volume

Volume 68,035

Quotes are delayed by 20 min

/zigman2/quotes/203808743/composite

Previous close

$ 322.08

$ 323.27

Change

+1.19 +0.37%

Day low

Day high

$321.08

$326.90

Open

52 week low

52 week high

$171.03

$338.20

Open

Company Description

Anthem, Inc. provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid, and Medicare markets. The company operates through the following segments: Commercial & Specialty Bus...

Anthem, Inc. provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid, and Medicare markets. The company operates through the following segments: Commercial & Specialty Business, Government Business and Other. The Commercial and Specialty Business segment includes local group, national accounts, and individual and specialty businesses. The Government Business segment includes medicare and medicaid businesses, national government services and services provided to the federal government in connection with federal employee program. Anthem was founded on November 30, 2004 and is headquartered in Indianapolis, IN.

Valuation

P/E Current

17.51

P/E Ratio (with extraordinary items)

16.58

P/E Ratio (without extraordinary items)

16.35

Price to Sales Ratio

0.75

Price to Book Ratio

2.41

Price to Cash Flow Ratio

12.97

Enterprise Value to Sales

0.95

Total Debt to Enterprise Value

0.21

Efficiency

Revenue/Employee

1,476,105.00

Income Per Employee

68,088.00

Total Asset Turnover

1.38

Liquidity

Current Ratio

1.65

Profitability

Operating Margin

6.46

Pretax Margin

5.74

Net Margin

4.61

Return on Assets

6.38

Return on Equity

15.95

Return on Total Capital

13.44

Return on Invested Capital

10.04

Capital Structure

Total Debt to Total Equity

65.32

Total Debt to Total Capital

39.51

Total Debt to Total Assets

26.48

Long-Term Debt to Equity

57.58

Long-Term Debt to Total Capital

34.83

Officers and Executives

Name Age Officer Since Title
Ms. Gail Koziara Boudreaux 58 2017 President, Chief Executive Officer & Director
Mr. John E. Gallina 59 2008 CFO-Comprehensive Health Solutions Business Unit
Ms. Gloria M. McCarthy 66 2005 Executive Vice President
Ms. Dorothy A. Coleman 56 2019 Senior VP & CFO-Government Business Division
Dr. Elizabeth Kwo - - Vice President-Clinical Data Analytics

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/01/2020 Gail Koziara Boudreaux
President and CEO; Director
14,764   Derivative/Non-derivative trans. at $313.9 per share. 4,634,419
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
300   Disposition at $337 per share. 101,100
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
675   Disposition at $335.92 per share. 226,746
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
1,193   Disposition at $334.87 per share. 399,499
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
1,200   Disposition at $333.97 per share. 400,764
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
1,056   Disposition at $332.86 per share. 351,500
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
400   Disposition at $331.92 per share. 132,768
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
1,010   Disposition at $330.77 per share. 334,077
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
927   Derivative/Non-derivative trans. at $146.93 per share. 136,204
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
781   Derivative/Non-derivative trans. at $100.77 per share. 78,701
11/09/2020 Ronald William Penczek
SVP, Chief Accounting Officer
1,199   Disposition at $330.75 per share. 396,569
11/03/2020 Thomas C. Zielinski
EVP & General Counsel
1,893   Disposition at $292.32 per share. 553,361
11/03/2020 Thomas C. Zielinski
EVP & General Counsel
2,500   Disposition at $292.35 per share. 730,875
11/03/2020 Thomas C. Zielinski
EVP & General Counsel
2   Disposition at $292.64 per share. 585
11/03/2020 Thomas C. Zielinski
EVP & General Counsel
4,780   Disposition at $292.07 per share. 1,396,094
11/03/2020 Thomas C. Zielinski
EVP & General Counsel
1,893   Derivative/Non-derivative trans. at $232.04 per share. 439,251
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
1,167   Disposition at $295 per share. 344,265
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
147   Disposition at $293.98 per share. 43,215
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
1,120   Disposition at $293.33 per share. 328,529
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
1,600   Disposition at $292.13 per share. 467,408
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
800   Disposition at $290.3 per share. 232,240
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
1,000   Disposition at $287.58 per share. 287,580
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
4,667   Derivative/Non-derivative trans. at $100.77 per share. 470,293
10/09/2020 Peter D. Haytaian
EVP & President, Commercial
1,167   Disposition at $295 per share. 344,265
10/02/2020 Peter D. Haytaian
EVP & President, Commercial
4,667   Disposition at $280 per share. 1,306,760
10/02/2020 Peter D. Haytaian
EVP & President, Commercial
2,592   Derivative/Non-derivative trans. at $100.77 per share. 261,195
10/02/2020 Peter D. Haytaian
EVP & President, Commercial
2,075   Derivative/Non-derivative trans. at $89.44 per share. 185,588
10/01/2020 Jeffrey D. Alter
EVP, IngenioRx & Anthem Health
2,746   Award at $0 per share. 0
09/04/2020 Prakash R. Patel
EVP & President, DBG
118   Derivative/Non-derivative trans. at $276.22 per share. 32,593
07/02/2020 Felicia Farr Norwood
EVP & President, GBD
231   Derivative/Non-derivative trans. at $267 per share. 61,677
/news/latest/company/us/antm

MarketWatch News on ANTM

  1. Managed-Care Rallies on Prospects for a Divided Congress

    2:10 p.m. Nov. 4, 2020

    - Daren Fonda

  2. Managed-Care Stocks, and Anthem, Could Rise After Vote

    11:28 a.m. Nov. 3, 2020

    - Daren Fonda

  3. Anthem profit falls as costs rise

    6:29 a.m. Oct. 28, 2020

  4. UnitedHealth Group Inc. stock rises Friday, outperforms market

    4:25 p.m. Sept. 25, 2020

    - MarketWatch Automation

  5. UnitedHealth Group Inc. stock rises Thursday, still underperforms market

    4:25 p.m. Sept. 24, 2020

    - MarketWatch Automation

  6. UnitedHealth Group Inc. stock falls Wednesday, still outperforms market

    4:25 p.m. Sept. 23, 2020

    - MarketWatch Automation

  7. UnitedHealth Group Inc. stock falls Tuesday, underperforms market

    4:25 p.m. Sept. 22, 2020

    - MarketWatch Automation

  8. UnitedHealth Group Inc. stock falls Monday, underperforms market

    4:25 p.m. Sept. 21, 2020

    - MarketWatch Automation

  9. UnitedHealth Group Inc. stock outperforms market on strong trading day

    4:25 p.m. Sept. 18, 2020

    - MarketWatch Automation

  10. Google-Backed American Well Stock Rises 28% in Market Debut

    5:15 p.m. Sept. 17, 2020

    - Luisa Beltran

  11. UnitedHealth Group Inc. stock falls Wednesday, still outperforms market

    4:25 p.m. Sept. 16, 2020

    - MarketWatch Automation

  12. UnitedHealth Group Inc. stock rises Wednesday, still underperforms market

    4:25 p.m. Sept. 9, 2020

    - MarketWatch Automation

  13. UnitedHealth Group Inc. stock falls Tuesday, still outperforms market

    4:25 p.m. Sept. 8, 2020

    - MarketWatch Automation

  14. Loading more headlines...
/news/nonmarketwatch/company/us/antm

Other News on ANTM

  1. Dividend Champion And Contender Highlights: Week Of November 29

    9:15 a.m. Nov. 28, 2020

    - Seeking Alpha

  2. Is Anthem (ANTM) a Potential Stock for Value Investors?

    10:38 a.m. Nov. 27, 2020

    - Zacks.com

  3. Unpopular Cigna May Become Very Rewarding

    8:29 a.m. Nov. 26, 2020

    - Seeking Alpha

  4. The Top 5 Telehealth Stocks Disrupting the Healthcare Sector

    11:25 a.m. Nov. 25, 2020

    - InvestorPlace.com

  5. 3 New, Undervalued Predictable Stocks

    1:37 p.m. Nov. 20, 2020

    - GuruFocus.com

  6. Top Buys From The Best Money Managers (Q3 2020)

    3:29 p.m. Nov. 18, 2020

    - Seeking Alpha

  7. Humana (HUM) Enhances Its Services in Washington Counties

    12:07 p.m. Nov. 18, 2020

    - Zacks.com

  8. Does UnitedHealth Have Renewed Interest in Buying Amwell?

    1:56 p.m. Nov. 16, 2020

    - GuruFocus.com

  9. 3 High-Return Stock Picks

    10:16 a.m. Nov. 13, 2020

    - GuruFocus.com

  10. Loading more headlines...

At a Glance

Anthem, Inc.

220 Virginia Avenue

Indianapolis, Indiana 46204

Phone

1 8003311476

Industry

Life Insurance

Sector

Financial Services

Fiscal Year-end

12/2020

Revenue

$104.21B

Net Income

$4.81B

2019 Sales Growth

13.1%

Employees

70,600

/news/pressrelease/company/us/antm

Press Releases on ANTM

  1. AM Best Affirms Credit Ratings of Anthem, Inc. and Its Subsidiaries

    6:20 p.m. Dec. 3, 2020

    - BusinessWire - BZX

  2. Loading more headlines...
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.